CN114717250B - Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application - Google Patents
Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application Download PDFInfo
- Publication number
- CN114717250B CN114717250B CN202210150422.1A CN202210150422A CN114717250B CN 114717250 B CN114717250 B CN 114717250B CN 202210150422 A CN202210150422 A CN 202210150422A CN 114717250 B CN114717250 B CN 114717250B
- Authority
- CN
- China
- Prior art keywords
- cordyceps militaris
- cordycepin
- gsda
- gnda
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 title claims abstract description 50
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 title claims abstract description 50
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000012269 metabolic engineering Methods 0.000 title claims abstract description 12
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 57
- 239000007788 liquid Substances 0.000 claims abstract description 26
- 238000000855 fermentation Methods 0.000 claims abstract description 23
- 230000004151 fermentation Effects 0.000 claims abstract description 23
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims abstract description 20
- 230000002018 overexpression Effects 0.000 claims abstract description 13
- 239000013598 vector Substances 0.000 claims abstract description 11
- 108010029731 6-phosphogluconolactonase Proteins 0.000 claims abstract description 9
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims abstract description 9
- 102100031126 6-phosphogluconolactonase Human genes 0.000 claims abstract description 8
- 238000005516 engineering process Methods 0.000 claims abstract description 5
- 108020001657 6-phosphogluconate dehydrogenase Proteins 0.000 claims abstract description 4
- 102000004567 6-phosphogluconate dehydrogenase Human genes 0.000 claims abstract description 4
- 238000012795 verification Methods 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 239000002609 medium Substances 0.000 claims description 15
- 239000013612 plasmid Substances 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 13
- 239000001963 growth medium Substances 0.000 claims description 12
- 238000012216 screening Methods 0.000 claims description 11
- 241000588724 Escherichia coli Species 0.000 claims description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 238000001976 enzyme digestion Methods 0.000 claims description 9
- 101100184662 Caenorhabditis elegans mogs-1 gene Proteins 0.000 claims description 8
- 238000012408 PCR amplification Methods 0.000 claims description 7
- 239000002299 complementary DNA Substances 0.000 claims description 7
- 239000000725 suspension Substances 0.000 claims description 7
- 238000012258 culturing Methods 0.000 claims description 6
- 239000013604 expression vector Substances 0.000 claims description 6
- 238000012163 sequencing technique Methods 0.000 claims description 6
- 229940024606 amino acid Drugs 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 claims description 5
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims description 5
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 4
- 229960004261 cefotaxime Drugs 0.000 claims description 4
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 claims description 4
- 235000002639 sodium chloride Nutrition 0.000 claims description 4
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 claims description 3
- 229960003669 carbenicillin Drugs 0.000 claims description 3
- 229930027917 kanamycin Natural products 0.000 claims description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 3
- 229960000318 kanamycin Drugs 0.000 claims description 3
- 229930182823 kanamycin A Natural products 0.000 claims description 3
- 238000009630 liquid culture Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 3
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 2
- 241000589158 Agrobacterium Species 0.000 claims description 2
- 241000190633 Cordyceps Species 0.000 claims description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 2
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- 229930003270 Vitamin B Natural products 0.000 claims 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims 1
- 235000019797 dipotassium phosphate Nutrition 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 1
- 235000019156 vitamin B Nutrition 0.000 claims 1
- 239000011720 vitamin B Substances 0.000 claims 1
- 101150069116 gndA gene Proteins 0.000 abstract description 34
- 101150050773 GSDA gene Proteins 0.000 abstract description 25
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 18
- 230000003834 intracellular effect Effects 0.000 abstract description 7
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 230000009466 transformation Effects 0.000 abstract description 2
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 239000003550 marker Substances 0.000 description 21
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000012634 fragment Substances 0.000 description 8
- 239000002028 Biomass Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 101150073246 AGL1 gene Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 244000061458 Solanum melongena Species 0.000 description 4
- 235000002597 Solanum melongena Nutrition 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- BIRSGZKFKXLSJQ-SQOUGZDYSA-N 6-Phospho-D-gluconate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O BIRSGZKFKXLSJQ-SQOUGZDYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003208 gene overexpression Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 102000010705 glucose-6-phosphate dehydrogenase activity proteins Human genes 0.000 description 3
- 108040005050 glucose-6-phosphate dehydrogenase activity proteins Proteins 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 230000004108 pentose phosphate pathway Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003259 recombinant expression Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 241000486634 Bena Species 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- IJOJIVNDFQSGAB-SQOUGZDYSA-N 6-O-phosphono-D-glucono-1,5-lactone Chemical compound O[C@H]1[C@H](O)[C@@H](COP(O)(O)=O)OC(=O)[C@@H]1O IJOJIVNDFQSGAB-SQOUGZDYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000719 anti-leukaemic effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010209 regulation of pentose-phosphate shunt Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/38—Nucleosides
- C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01044—Phosphogluconate dehydrogenase (decarboxylating) (1.1.1.44)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01049—Glucose-6-phosphate dehydrogenase (1.1.1.49)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategies and application thereof. The invention utilizes agrobacterium tumefaciens mediated genetic transformation technology to introduce the recombinant vector of the overexpression glucose-6-phosphate dehydrogenase encoding gene gsdA and/or 6-phosphogluconate dehydrogenase encoding gene gndA into cordyceps militaris, so as to construct a cordyceps militaris recombinant strain, strengthen the supply of intracellular NADPH and remarkably improve the fermentation yield of cordycepin through liquid submerged fermentation. The yield of 20d cordycepin obtained by liquid fermentation of the recombinant strain over-expressing gsdA reaches 191.95mg/L, which is 150.86% higher than that of wild Cordyceps militaris; the recombinant strain of the overexpressed gndA has the yield of 20d cordycepin of 764.48mg/L by liquid fermentation, which is 1034.02 percent higher than that of wild cordyceps militaris. The method for reconstructing the cordyceps militaris strain to construct the recombinant engineering strain based on the cofactor metabolic engineering strategy provides a new direction for breeding the cordyceps militaris strain with high cordycepin yield.
Description
Technical Field
The invention relates to a method for improving cordycepin yield of cordyceps militaris by utilizing cofactor metabolic engineering strategies, and belongs to the technical field of bioengineering.
Background
Cordyceps militaris (Cordyceps militaris) is a traditional fungus for both medicine and food in China, is Cordyceps of Clavipitaceae of Ascomycetes, and has high medicinal value and nutritive value. Researches show that the chemical components of the cordyceps militaris comprise various active components such as Cordycepin, adenosine, polysaccharide, fatty acid, amino acid, ergosterol and the like, and the Cordycepin (Cordycepin) is one of the main active components and is also an important index for evaluating the quality of the cordyceps militaris. The pharmacological activity of cordycepin includes anti-tumor, anti-mutation, antifungal, immunoregulation and other aspects, and the cordycepin has been used as a new anticancer and anti-leukemia medicine in the United states for clinical trial. The traditional cordycepin is extracted from natural cordyceps militaris (but with lower content), and the natural cordyceps militaris grows slowly and is excessively developed, so that market demands cannot be met, and the cordycepin price is increased, and the current selling price exceeds 500000 dollars/kg. Cordycepin can be obtained by chemical synthesis and biological methods. The chemical synthesis method has the advantages of high raw material cost, complex process, low yield and more byproducts, and limits the industrial application of the chemical synthesis method; the biological method for synthesizing cordycepin mainly adopts a liquid fermentation mode, and the liquid fermentation has the advantages of easy control of fermentation process, short period and the like compared with other methods. At present, the measures for improving the cordycepin yield mainly accumulate a great deal of work in the aspects of strain improvement, process technology optimization and the like, such as mutation breeding, carbon source utilization efficiency improvement, precursor supply improvement and the like.
Cofactor metabolic engineering strategies are based on the regulation of cofactors (NADPH/NADP) for intracellular key enzymes + 、NADH/NAD + ATP/ADP, etc.), increases the metabolic pathway flow of the target product, and increases the yield of the target metaboliteHas been successfully applied to various microorganisms such as Saccharomyces cerevisiae, aspergillus niger, etc. Cofactors are basic regulators in organisms, involved in various biological processes (e.g., energy metabolism, anti-redox pressure, cell senescence/death, etc.), and are cooperatively involved in regulating the same biological response. NADP (NADP) + NADPH is one of the important cofactors in organisms, and NADPH acts as a reducing power affecting the synthesis reaction of amino acids, lipids and nucleotides. Thus, adequate NADPH supply is necessary to maintain intracellular redox balance and amino acid biosynthesis.
The pentose phosphate pathway is critical for maintaining intracellular NADPH production, and regulation of pentose phosphate pathway flux is an important strategy for cofactor metabolic engineering, and intracellular NADPH/NADP is regulated by increasing the enzymatic activities of glucose-6-phosphate dehydrogenase (G6 PDH), 6-phosphogluconate dehydrogenase (6 PGD), and other key enzymes involved in NADPH synthesis + Balance, and further regulate product synthesis. G6PDH is a key regulator enzyme of the first reaction of the pentose phosphate pathway, catalyzing the conversion of glucose-6-phosphate to 6-phosphogluconolactone and NADPH; the 6PGD catalyzes the third step of the pentose phosphate pathway, catalyzing the 6-phosphogluconate reaction to ribulose-5-phosphate and NADPH. Based on cofactor metabolic engineering strategies, the encoding gene of the over-expressed G6PDH or 6PGD strengthens intracellular NADPH supply, and the method has feasibility of improving cordycepin yield in cordyceps militaris.
Disclosure of Invention
The invention aims to reform Cordyceps militaris strain by over-expressing key enzyme coding genes participating in NADPH synthesis based on cofactor metabolic engineering strategy and applying genetic engineering technology, strengthen intracellular NADPH supply and obtain Cordyceps militaris recombinant strain with high cordycepin yield.
In order to achieve the above purpose, the present invention adopts the following technical scheme:
the primary purpose of the invention is to request the application of over-expressed key enzyme coding genes involved in NADPH synthesis in improving cordycepin yield, wherein the gene gsdA for the key enzyme (G6 PDH or 6 PGD) for NADPH synthesis has a sequence shown as SEQ ID NO.3, and the gene gndA has a sequence shown as SEQ ID NO. 4.
The invention provides a method for improving cordycepin yield based on cofactor metabolic engineering strategies, which comprises the steps of constructing a cordycepin mutant strain with target gene over-expression through a genetic engineering means; the target gene is glucose-6-phosphate dehydrogenase (G6 PDH) encoding gene gsdA or glucose-6-phosphate dehydrogenase (6 PGD) encoding gene gndA.
Specifically, the recombinant strain of Cordyceps militaris over-expressing gsdA or gndA gene is constructed by the following method:
(1) Extracting mRNA of Cordyceps militaris C.militaris, reversely recording and preparing cDNA, and cloning gsdA or gndA genes by taking the cDNA as a template;
(2) Connecting a linearization vector with a target gene gsdA or gndA, transferring into an escherichia coli DH5 alpha competent cell, and screening to obtain escherichia coli of a gene overexpression plasmid pDHt-SK-BenA-gsdA/gndA after PCR amplification, enzyme digestion and sequencing verification;
(3) Transferring the plasmid into agrobacterium tumefaciens Agrobacterium tumefaciensAGL, culturing by using a YEB solid screening culture medium (containing 50-100 mug/mL carbenicillin and 50-100 mug/mL kanamycin), and screening after PCR verification and enzyme digestion verification to obtain the agrobacterium tumefaciens containing the plasmid pDHt-SK-BenA-gsdA/gndA;
(4) After agrobacterium tumefaciens (containing plasmid pDHt-SK-BenA-gsdA/gndA) is subjected to induction culture by an IM liquid culture medium, co-culturing with a wild cordyceps militaris C.militaris spore suspension, and screening by using an M-100 solid culture medium (containing cefotaxime and benomyl) resistance to obtain a cordyceps militaris recombinant strain;
(5) Extracting genome from the Cordyceps militaris recombinant strain obtained by screening, performing shake flask liquid fermentation after PCR verification is correct, detecting cordycepin yield in fermentation broth by HPLC, and screening to obtain Cordyceps militaris recombinant strain with improved cordycepin yield;
(6) And carrying out subculture for multiple times and carrying out liquid fermentation verification to finally obtain the Cordyceps militaris recombinant strain with high cordycepin yield and stable inheritance.
Further, the gene symbol of the glucose-6-phosphate dehydrogenase gene in the step (1) is gsdA, genebank nucleotide sequence number CCM_06983; the gene symbol of the gluconic acid-6-phosphate dehydrogenase gene is gndA, genebank nucleotide sequence number CCM_06873. The target gene gsdA (or gndA) is obtained by amplifying cordyceps militaris cDNA by utilizing a PCR technology, wherein the cordyceps militaris is C.militaris CGMCC3.14242, and the gsdA/gndA gene PCR amplification primer pairs are respectively as follows:
gsdA-F:5’-ATGATGCACAAGACCATTAAGAACA-3’;
gsdA-R:5’-TTACAGCTTGTTGCTAGAGTTGTTGT-3’;
gndA-F:5’-ATGTCTGGTCCTGTTGCTCGA-3’;
gndA-R:5’-TTAAGCCTGGTAGGTAGAGGCAG-3’。
further, the linearization vector in the step (2) is pDHt-SK-BenA, and the gene sequence of the BenA is shown in SEQ ID NO. 5.
Further, the components (g/L) of the YEB solid medium in the step (3) are as follows: peptone 10, sucrose 5, yeast extract 1, mgSO 4 ·7H 2 O0.5, agar powder 20.
Further, the culture medium in the step (4) comprises the following components:
IM liquid medium (g/L): 400mL of 2.5 XMM salt, 1.8g of glucose, 5mL of glycerol (40 mL of 1M MES and 20mL of 10mMAS were added after sterilization and cooling to 50 ℃). Wherein the MM salt (g/L) comprises: KH (KH) 2 PO 4 3.625、K 2 HPO 4 6.72、MgSO 4 ·7H 2 O 1.250、NaCl 0.375、CaCl 2 0.125、FeSO 4 ·7H 2 O 0.0062、(NH 4 ) 2 SO 4 1.250。
IM solid medium (g/L): 400mL of 2.5 XMM salt, 0.9g of glucose, 5mL of glycerol, and 14g of agar (40 mL of 1M MES and 20mL of 10mMAS were added after sterilization and cooling to 50 ℃).
Further, the cordyceps militaris recombinant strain liquid fermentation medium in the step (5) comprises the following components:
a synthetic medium (ZL 2020111857983) is used, which comprises glucose, inorganic salts, amino acids and vitamin B 1 ;
The method specifically comprises the following steps: glucose 20-50g/L, ammonium sulfate 5-10g/L, dipotassium hydrogen phosphate 0.5-1g/L, potassium dihydrogen phosphate 0.5-1g/L, magnesium sulfate 0.5-10g/L, zinc sulfate 0.5-15g/L, glycine 5-10g/L, 0.5-1g/L aspartic acid, 0.5-2g/L glutamine, 0.1-0.5g/L tyrosine, 0.05-0.2g/L cysteine, 0.5-1g/L leucine, 0.5-2g/L lysine, 0.05-0.5g/L phenylalanine, vitamin B 1 0.1-1g/L。
Compared with the prior art, the invention has the beneficial effects that: the strain with the gene overexpression of the gsdA (or gndA) is constructed by a genetic engineering technical means, compared with a wild strain, the yield of cordycepin is obviously improved by the recombinant strain gsdA-OE and the recombinant strain gndA-OE, the yield of the cordycepin obtained by liquid submerged fermentation of 20d reaches 191.95 +/-7.67 mg/L and 764.48 +/-12.80 mg/L respectively, and the fermentation yield of the strain is respectively improved by 150.86% and 1034.02% compared with that of the wild strain, so that a new direction is provided for breeding the strain with the cordycepin produced in high yield.
Drawings
FIG. 1 shows the PCR amplification results of the promoter, terminator and target gene on the over-expression vector constructed according to the present invention. Wherein, (a) M: DL2000 DNA Marker,1-2: gpd master; (b) M: DL2000 DNA Marker,1-2: NOS terminator; (c) M DL5000 DNA Marker,1-2: a gsdA fragment; (d) M: DL2000 DNA Marker,1-2: a gndA fragment; (e) M: DL10000 DNA Marker,1-2: pDHt-SK-BenA double cleavage (SpeI-HF & EcoRI-HF).
FIG. 2 shows the PCR positive identification result of the gsdA overexpression vector constructed according to the invention. Wherein, (a) the M is DL5000 DNA Marker,1-2 is pDHt-SK-BenA-gsdA (E.coli DH5 alpha) bacterial liquid PCR verification; (b) M: DL5000 DNA Marker,1: pDHt-SK-BenA-gsdA (E.coli DH 5. Alpha.) plasmid PCR verification; (c) M: DL15000 DNA Marker,1-3: pDHt-SK-BenA-gsdA (E.coli DH 5. Alpha.) enzyme digestion verification; (d) M: DL5000 DNA Marker,1: pDHt-SK-BenA-gsdA (Agrobacterium tumefaciens AGL 1) bacterial liquid PCR verification; (e) M: DL2000 DNA Marker,1: pDHt-SK-BenA-gsdA (Agrobacterium tumefaciens AGL 1) plasmid PCR verification; (f) M: DL15000 DNA Marker,1-3: pDHt-SK-BenA-gsdA (Agrobacterium tumefaciens AGL 1) enzyme digestion verification.
FIG. 3 shows the PCR positive identification result of the gndA overexpression vector constructed in the invention. Wherein, (a) M is DL5000 DNA Marker,1 is pDHt-SK-BenA-gndA (E.coli DH5 alpha) bacterial liquid PCR verification; (b) M: DL15000 DNA Marker,1-2: pDHt-SK-BenA-gndA (E.coli DH 5. Alpha.) plasmid PCR verification; (c) M: DL15000 DNA Marker,1-3: pDHt-SK-BenA-gndA (E.coli DH 5. Alpha.) enzyme digestion verification; (d) M: DL5000 DNA Marker,1: pDHt-SK-BenA-gndA (Agrobacterium tumefaciens AGL 1) bacterial liquid PCR verification; (e) M: DL10000 DNA Marker,1: pDH t-SK-BenA-gndA (Agrobacterium tumefaciens AGL 1) plasmid PCR verification; (f) M: DL15000 DNA Marker,1-3: pDHt-SK-BenA-gndA (Agrobacterium tumefaciens AGL 1) enzyme digestion verification.
FIG. 4 shows the PCR positive identification result of the cordyceps militaris transformed by the over-expression vector constructed by the invention. Wherein, (a) M is DL2000 DNA Marker,1-4 is that simple genomic DNA of gsdA over-expression transformant is extracted as template PCRBenA fragment (901 bp); (b) Extracting genomic DNA of the gsdA over-expression transformant as a template for PCR, wherein M is DL2000 DNA Marker,1-5: gsdA-BenA (1980 bp); (c) DL2000 DNA Marker,1-3, extracting simple genomic DNA of the gndA over-expression transformant as a template PCR BenA fragment (901 bp); (d) Extracting genomic DNA of the gndA over-expression transformant as a template for PCR, wherein M is DL2000 DNA Marker,1-2: gndA-BenA (1880 bp).
FIG. 5 shows the liquid fermentation phenotype parameters of the Cordyceps militaris mutant strain over-expressing the gsdA/gndA gene constructed in the invention. Wherein, (a-c): biomass (a), residual sugar concentration (b) and cordycepin concentration (c) profiles of gsdA over-expression and control groups; (d-f): biomass (d), residual sugar concentration (e) and cordycepin concentration (f) profiles for the gndA overexpressed and control groups.
FIG. 6 is a flow chart of a recombinant plasmid over-expressing glucose-6-phosphate dehydrogenase/gluconic acid-6-phosphate dehydrogenase constructed according to the present invention. (a) pDHt-SK-BenA-gsdA; (b) pDHt-SK-BenA-gndA.
Detailed Description
The invention is further illustrated below in connection with specific examples, but the scope of the invention is not limited thereto, as set forth in the following claims. The Cordyceps militaris strain C.militaris and the agrobacterium tumefaciens A.tumefaciens AGL1 are all known strains in the art and can be obtained from commercial sources. The Cordyceps militaris used in the embodiment is C.militaris CGMCC3.14242 and is preserved by China general microbiological culture Collection center.
Example 1: construction of recombinant expression vector pDHt-SK-BenA-gsdA/gndA
The gsdA/gndA gene, gpd promoter and nos terminator fragment (FIG. 1) were PCR amplified using the primers shown in Table 1 with the cDNA of C.militaris CGMCC3.14242 as a template, and the target fragment was recovered using a DNA gel recovery kit (Nannunofizan Biotechnology Co., ltd.). And (3) carrying out gene sequencing on the gel-collected products by the large gene technology Co-Ltd, and selecting PCR gel-collected products with correct sequencing for subsequent experiments.
The pDHt-SK-BenA expression vector stored in this laboratory was subjected to double digestion (SpeI-HF, ecoRI-HF) (FIG. 1), and the gpd promoter fragment, the gsdA/gndA gene fragment, and the nos terminator fragment were ligated to the linearized expression vector pDHt-SK-BenA using ClonExpress Ultra One Step Cloning Kit (Nanjinouzan Biotechnology Co., ltd.), to finally construct the gsdA/gndA overexpression plasmid pDHt-SK-BenA-gsdA/gndA.
TABLE 1 primers used in this experiment
Example 2: agrobacterium tumefaciens AGL 1-mediated pDHt-SK-BenA-gsdA/gndA transfer to Cordyceps militaris
The recombinant plasmid pDHt-SK-BenA-gsdA/gndA is transferred into escherichia coli DH5 alpha by a chemical conversion method to obtain a large number of recombinant expression plasmids, and sequencing verification is carried out by Hua big gene technology Co. Further, the recombinant plasmid pDHt-SK-BenA-gsdA/gndA is transferred into the agrobacterium tumefaciens AGL1 by a chemical conversion method, and the agrobacterium tumefaciens AGL1 containing the pDHt-SK-BenA-gsdA/gndA plasmid is obtained through PCR verification and enzyme digestion verification. YEB medium (g/L) used for Agrobacterium tumefaciens culture: peptone 10, sucrose 5, yeast extract 1, mgSO 4 ·7H 2 O0.5; the solid culture medium is added with 20g of agar powder. LB liquid medium (g/L): tryptone 10, yeast extract 5, naCl 10, pH 7.0; the solid culture medium is added with 20g of agar powder.
Recombinant plasmid using agrobacterium-mediated transformationpDHt-SK-BenA-gsdA/gndA is transferred into Cordyceps militaris Cordyceps militaris CGMCC3.14242 to obtain Cordyceps militaris transformant. The transformation process is as follows: agrobacterium tumefaciens AGL1 containing recombinant expression plasmid was added to liquid YEB resistant medium (carbenicillin and kanamycin), cultured overnight at 28℃at 220rpm, and then the cells were collected, and then an appropriate amount of IM liquid medium was added to resuspend the cells (OD 600 About 0.15), further induced culture at 28℃at 150rpm to OD 600 =0.5 to 0.8. Mixing the induced Agrobacterium tumefaciens AGL1 bacterial liquid and freshly prepared Cordyceps militaris spore suspension in a 1.5mL sterile EP tube, uniformly coating 100 mu L of the mixed liquid on an IM solid culture medium, and culturing for 2-3d at 28 ℃ in an inversion way. Then, a proper amount of M-100 solid resistant medium (containing cefotaxime and benomyl) is added to the plate, and the culture is continued at 25 ℃ until single colonies grow. The colonies were picked up on a new M-100 resistant medium plate for secondary screening, colonies on the secondary screening plate were subjected to shaking culture with SDB liquid medium, mycelium genome was extracted for PCR verification, and primers used are shown in Table 1.
Example 3: cordyceps militaris eggplant bottle culture and preparation of spore suspension
Filling a proper volume of natural solid culture medium into an eggplant bottle, sterilizing, inoculating proper amount of Cordyceps militaris recombinant strain mycelium after the eggplant bottle is solidified, and standing at 25 ℃ for 20-25d. Adding appropriate amount of physiological saline into the bottle of the eggplant with the vigorous Cordyceps militaris mycelia, stirring with a sterile glass rod, filtering the liquid in the bottle with three layers of gauze to obtain spore suspension, and calculating the spore concentration.
Example 4: determination of cordycepin content in cordyceps militaris fermentation broth
The cordycepin content in the fermentation broth is detected by high performance liquid chromatography, and the conditions of the high performance liquid chromatography are as follows: waters e2695, waters 2998, 260nm ultraviolet detector wavelength, venusil MP C18 (2) (4.6X105 mm,5 μm) column temperature setting room temperature, mobile phase condition methanol: water, flow rate 0.8-1.0mL/min, and sample injection amount 10-20 μl.
Example 5: liquid fermentation of recombinant strain of Cordyceps militaris and cordycepin content determination
Selecting Cordyceps militaris strain C.militaris CGMCC3.14242 as a control group, and performing submerged liquid fermentation of the Cordyceps militaris recombinant strain over-expressing gsdA/gndA. A250 mL conical flask is used for carrying out a liquid submerged fermentation experiment, cordyceps militaris spore suspension is inoculated according to 1% of inoculation amount, and the cordyceps militaris spore suspension is subjected to shaking culture for 20-30d at the temperature of 25-28 ℃ and the speed of 160-180r/min, and the biomass concentration, the residual sugar concentration and the cordycepin yield are sampled and measured (figure 5).
When glucose-6-phosphate dehydrogenase (gsdA) is overexpressed, glucose consumption was slower for the first 5 days than for the control, with the rate of glucose consumption being significantly higher at residues 5-10d than in the wild-type (control) and the substrates glucose was substantially depleted for both groups 10 d. From the growth curve, the gsdA-OE group grows slower than the control group, the biomass concentration of the fermentation 10d is 13.13+/-0.32 g/L, and the biomass concentration of the control group reaches 14.73+/-0.42 g/L; the over-expression of glucose-6-phosphate dehydrogenase (gsdA) enhances the synthesis capacity of cordycepin, and the yield of the cordycepin reaches 191.95 +/-7.67 mg/L at 20d, which is improved by 150.86 percent compared with a control group.
When overexpressing 6-phosphogluconate dehydrogenase (gndA), the glucose consumption curve has the same trend as the gsdA-OE group. From the growth curve, the growth rate of the wild strain is higher than that of the gndA-OE group in the first 5 days, the growth rate of the experimental group of 5-10 days is greatly improved, the biomass concentration of the fermentation 10d is 13.78+/-1.14 g/L, and the biomass concentration of the control group reaches 13.63+/-0.62 g/L; from the cordycepin synthesis curve, the yield of the 20d cordycepin reaches 764.48 +/-12.80 mg/L, and is improved by 1034.02 percent compared with the control group.
The result shows that after the gsdA or gndA (encoding the key enzyme G6PDH or 6PGD synthesized by NADPH) is overexpressed, the cordycepin synthesis capability of the recombinant strain of the Cordyceps militaris is obviously improved compared with that of the wild strain, and the enhancement of the supply of the cofactor NADPH is helpful for the biosynthesis of cordycepin.
Sequence listing
<110> university of Dalian industry
<120> method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application
<160> 5
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1035
<212> DNA/RNA
<213> gpd promoter sequence (Artificial sequence)
<400> 1
ggccaatttg tctattctgg tagttccgcc gtggccaact tgacggttca ctggttttgt 60
gtcttgatga ctgacaaaga gggccagaga tgagacgacg agctgccggt tgcaccatca 120
gccaaccgtt cgcagaaatc atcagttgcg ctacagtcaa catagcgggt ggtcaaagtt 180
tgcgtgggca cgggttgccg cacgagttgg aacgtcagta aagtggggga ggggaagcaa 240
ccagaacgag gccaattgaa tgggatgaag gcgtctggga gggaagcacg agcgtgaatg 300
aatggacggt tgcgtgactc tggtctcgcg atttcgatcg agtcaaggaa cccgtatggt 360
tgcctcttgt cttggagagc tcgtcgaggc ccaagctgcg agtatatggt tggtgatgcg 420
ctgggcattt gcccctctct gcccctccat ggacggacct gcagctcttg ggctggcaag 480
gtgttgcgct acgtcgagat gcggttaggt aagctggcat aagctggcat aaggttggct 540
gttcttgaga aatcaggcca gcagtcttgc acctctctgg ctacaggctc tccagcggtc 600
agccaccgcc actccagcgc ctgtttttca ctgacgatgg ccttgttttt ttgttgctct 660
ggcagctggc aagctgggtc ccggcagctg ccacggccaa gccacccagg actacaaaac 720
catttgccca cccctcctct tcgccgtgcg tctcttcttt ttctcccctc cattacacct 780
cattcttcag ttcaaaggaa caaaagtgag ttttccatcc gtcccacacc tggctccatc 840
atctcgagct tcattgcttc ttgaccatct accacgctct accctccaac agcttcgctc 900
acccaagagc tgcctgcttt tcccctcctc tccacgaccc cgccatccac cacttaacct 960
aaagttaccc ctcgctaacc gccaaacgtc ccaacaggtt tttcttctct cacctcactt 1020
ttctaatcaa gaaca 1035
<210> 2
<211> 253
<212> DNA/RNA
<213> NOS terminator sequence (Artificial sequence)
<400> 2
gatcgttcaa acatttggca ataaagtttc ttaagattga atcctgttgc cggtcttgcg 60
atgattatca tataatttct gttgaattac gttaagcatg taataattaa catgtaatgc 120
atgacgttat ttatgagatg ggtttttatg attagagtcc cgcaattata catttaatac 180
gcgatagaaa acaaaatata gcgcgcaaac taggataaat tatcgcgcgc ggtgtcatct 240
atgttactag atc 253
<210> 3
<211> 1830
<212> DNA/RNA
<213> gsdA Gene sequence (Artificial sequence)
<400> 3
atgatgcaca agaccattaa gaacatccag aacacctact acaagaccga caccgccgcc 60
ggccagaccc ccggcgccgg ccccggcgtt acctacctgg aatctgaccg tgctttcggc 120
taccagcgaa ttattcccag cagcgctatt gctctggtta gcaagtcgcg tcccaagctc 180
gacctccagc agctgaacgg cctgtcgtct tctagcttcc ccctgtctcc cacccgccac 240
tcgtcgtctt ggaccgcttc tagcctccga ttcaacttcc gaccctcgcg tccccccccc 300
tggtctaagc ccctgccaat ggagctgaag gagaacacca ccatcgttgt cctgggcgcc 360
tccggcgacc tcgctaagaa aaaaacctac cccgctctgt tcggcctgta ccgtaaccag 420
ttcctgccca aggacgtccg cattgttggc tacgcccgaa ccaagatgga ccacgaggag 480
tacctgcgtc gtattaagtc gtacatgaaa acccccacca aggagattga gcagcagctg 540
gaggagttct gcaagatttg ctcttacgtt tcgggccagt acgacaagga cgagtctttc 600
gaggctctca ccaagcacat ggaggagtta gaaaagggcc gtcccgagca caaccgactg 660
ttctacatgg ctctgccccc ctcggttttc accattgttt ctcagcacct caagaagtgc 720
tgctacccct ctaagggcat tgctcgtgtt atcgttgaga agcccttcgg caaggacctg 780
gccagcagcc gtgagttaca gaagtctctc gaacccgact ggaaggagga ggagctgtac 840
cgaattgacc actacctggg caaggagatg gttaagaaca tcctgattat gcgattcggc 900
aactctttcc tgggcgccac ctggaaccgt caccacattg acaacgtcca gatcaccttc 960
aaggagccct tcggcaccga gggccgtggc ggctacttcg acgagttcgg catcatccgt 1020
gacgtcatgc agaaccacct cctccaggtt ctcaccctcc tcgctatgga gcgtcccgtt 1080
tctttcgact ctgaggacat ccgtgacgag aaggtccgtg ttctgcgtgc tattagcgct 1140
ttggaaccca agaacgttat cattggccag tacggccgat cgctcgacgg ctctaagccc 1200
gcttacaagg aggacgacac cgttccccag gactcgcgat gccccacctt ctgcgctctg 1260
gttgcttaca ttaagaacga gcgatgggac ggcgttccct tcatcatgaa ggccggcaag 1320
gctctcaacg agcaaaagac cgagatcagg atacagttca aggacgttac ctcgggcatt 1380
ttcaaggaca ttccccgtaa cgagctggtt atgcgtatac agcccaacga gtcggtttac 1440
attaagatga actctaagct gcccggcctg tctatgcaga ccgttgttac cgagctggac 1500
ctcacctacc gccgtcgatt cagcgacctg aagattcccg aggcttacga gtcgctggtc 1560
ctggactgcc tgaagggcga ccactccaac ttcgttcgtg acgacgagct ggacgcttct 1620
tggcgtattt tcacccccct cctgcactac ctcgacgaca acaaggagat cattcctatg 1680
gagtacccct acggctcgcg tggccccgct gtcctggacg acttcaccgc ttcttacggc 1740
tacaagttct ctgacgccgc cggctaccag tggcccacca ccagcgctgt tccctctaac 1800
aacaacaaca actctagcaa caagctgtaa 1830
<210> 4
<211> 1593
<212> DNA/RNA
<213> gndA Gene sequence (Artificial sequence)
<400> 4
atgtctggtc ctgttgctcg actcgccaac atcaagcttg gctcccacga cagcaacaac 60
ccctcgtcca cgtctcctgc cactggcagt actcatccat tctcaagtgc taacaatgcc 120
cccagcgcgg atctcggcct cattggcctc gctgtcatgg gacagaacct gatcctcaac 180
atggccgatc acggcttcac catctgcgct ttcaaccgaa ccgtctccaa ggtcgaccac 240
ttcttggaaa atgaggccaa aggcaagtcc atcgtcggtg cccactccgt cgaagagttc 300
gtctccaagc tcaagacccc ccgccgcgtc atgctccttg tccaggccgg ccaggctgtc 360
gatgactgga ttgagaagct tctgcccctc ctggagaagg gtgacatcat tattgatggt 420
ggcaactcgc atttccccga ctctaaccgc cgcaccaagt acctcaccag caagggcctt 480
cgcttcgtcg gctccggtgt ttctggtggt gaggaaggtg cccgttacgg cccctccatc 540
atgcctggtg gtgatgagga agcttggcct catatcaagg aaatcttcca gggcatttct 600
gccaagtctg atggtgaggc ctgctgcgag tgggtcggtg acgagggtgc tggccactat 660
gttaagatgg ttcacaacgg tattgagtat ggtgacatgc agctcatctg cgaggcctac 720
gatatcatga agcgtgccct cggcctctcc aataaggaga tcggcgatgt cctcgccaag 780
tggaacaagg gtgttcttga ctctttcctc atcgaaatca cccgcgacat catgtacttc 840
aacgatgatg atggtaccgc cctcgtcgag aagattctcg acaaggccgg tcagaagggt 900
accggcaagt ggactgccgt caacgctctc gacctcggta tgcccgtcac cctcattgct 960
gaggctgtcc ttgccagatg cctgtctggc atcaaggagg agcgtgaggt tgcctcgacc 1020
aagctccagt acgtttcgcg caacagcggc aagttcgagg gcaacaagga gcaattcctc 1080
gatgatcttg agcaggctct ctacgcgtcc aagattatct cgtacgccca aggtttcatg 1140
ctgatgcagg aggctgccaa ggagtacggc tggaaactga acaagccctc gattgccctc 1200
atgtggcgtg gcggctgcat catccgctcc gtcttcctca aggacatcac cgccgcctac 1260
cgcaaggaca atgaccttgc caacctcctc ttcgacgact tcttcaacaa ggccatccac 1320
aaggcccagc ccggctggag agacgtcgtc gcccaggctg ctcagcttgg tatccctacc 1380
cccgccttct ctaccgctct gtcgtggttc gacggctacc gcaccaagga cctgcctgcc 1440
aacctgctcc aggcccagcg tgattacttt ggtgctcaca ccttccacat caagcctgag 1500
gctgccaacg ccaagtacca ggtcggcaag gacattcacg tcaactggac tggccgtggt 1560
ggcaacgtct ctgcctctac ctaccaggct taa 1593
<210> 5
<211> 1344
<212> DNA/RNA
<213> BenA Gene sequence (Artificial sequence)
<400> 5
atgcgtgaga ttgtccactt gcaaaccggc cagtgcggca accagattgg cgccgctttc 60
tggcagacca tctcgggcga gcacggcctc gacggctcgg gcgtttacaa cggcacctct 120
gacctccagc tagagcgtat gaacgtttac ttcaacgagg cgtccggcaa caagtacgtc 180
ccccgtgctg ttctggttga cctggagccc ggcactatgg acgctgttcg tgccggcccc 240
ttcggccagc tgttccgtcc cgacaacttc gttttcggcc agtctggcgc tggcaacaac 300
tgggctaagg gccactacac cgagggcgct gaactggttg accaggtcct ggacgttgtc 360
cgtcgtgagg ctgagggctg cgactgccta caaggcttcc agattaccca cagcctgggc 420
ggcggcaccg gcgccggcat gggcaccctc ctcatctcta agatccgtga ggagttcccc 480
gaccgaatga tggctacctt ctcggttgtc ccctcgccca aggtatcgga caccgttgtt 540
gagccctaca acgctaccct cagcgtccac cagctggtcg agaactctga cgctaccttc 600
tgcattgaca acgaggctct gtacgacatt tgtatgcgaa ccctgaagct gtctaacccc 660
tcctacggcg acctgaacca cctggttagc gctgttatgt cgggcgtcac cacctgcctg 720
cgattccccg gccagctcaa ctcggacctc cgaaagctcg ccgttaacat ggtccccttc 780
ccccgactgc acttcttcat ggttggcttc gctcccctca ccagccgcgg cgcccactct 840
ttccgcgccg ttaccgtccc cgagctgacc cagcagatgt acgaccccaa gaacatgatg 900
gccgcctcag acttccgaaa cggccgatac ctcacctgct ccgccatttt ccgtggcaag 960
gttagcatga aggaggtcga ggaccagatg cgtaacgttc agaacaagaa ctcttcttac 1020
ttcgtcgagt ggattcccaa caacgttcag accgccctgt gctctattcc cccccgtggc 1080
ctcaagatgt cgtctacctt cgttggcaac tctacctcta ttcaggagct gttcaagcgt 1140
gttggcgacc agttcaccgc tatgttccgt cgtaaggctt tcctccactg gtacaccggc 1200
gagggcatgg acgagatgga gttcaccgag gctgagtcta acatgaacga cctggtttcg 1260
gagtaccagc agtaccagga tgcctcgatc tctgagggcg aggaggagta cgaggaggag 1320
gttcccattg agggcgagga gtaa 1344
Claims (4)
1. A method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy is characterized in that:
the construction method of the cordyceps militaris recombinant strain comprises the following steps:
s1, extracting cordyceps militarisCordyceps militarisIs reversely recorded to prepare cDNA, and uses the cDNA as a template to clonegsdAOr (b)gndAA gene; genegsdAHas a sequence shown as SEQ ID NO.3, and a genegndAHas a sequence shown as SEQ ID NO. 4;
s2. The target GenegsdAOr (b)gndAAfter being connected with a linearization vector pDHt-SK-BenA, the gene is transferred intoIn the competent cells of the escherichia coli, the transformant is screened by PCR amplification, enzyme digestion and gene sequencing verification to obtain the recombinant vector containing pDHt-SK-BenA-gsdAOr pDHt-SK-BenA-gndAE.coli of (E.coli);
s3, extracting plasmids from escherichia coli containing the recombinant vector obtained in the step 2 by liquid culture, transferring the recombinant vector into competent cells of agrobacterium tumefaciens AGL-1, culturing and screening transformants by using a YEB solid medium containing 50-100 mug/mL carbenicillin and 50-100 mug/mL kanamycin, and obtaining the recombinant vector containing pDHt-SK-BenA after PCR amplification and enzyme digestion verificationgsdAOr pDHt-SK-BenA-gndAIs a root agrobacterium of (2);
s4, the recombinant vector pDHt-SK-BenA obtained in the step S3 is addedgsdAOr pDHt-SK-BenA-gndAAfter inducing and culturing the agrobacterium tumefaciens in an IM liquid culture medium, co-culturing the agrobacterium tumefaciens and a cordyceps militaris spore suspension on an IM solid culture medium, covering an M-100 solid culture medium containing cefotaxime and benomyl, screening cordyceps militaris transformants, further carrying out secondary screening on the cordyceps militaris transformants on the M-100 solid culture medium containing cefotaxime and benomyl, and obtaining the overexpression glucose-6-phosphate dehydrogenase encoding gene through PCR amplification and gene sequencing verificationgsdAOr 6-phosphogluconate dehydrogenase encoding genegndACordyceps militaris recombinant strain;
target genegsdAOr (b)gndAIn order to obtain the Cordyceps militaris cDNA by using PCR technology as template, the primer pair used for PCR amplification is
gsdA-F:5’-ATGATGCACAAGACCATTAAGAACA-3’;
gsdA-R:5’-TTACAGCTTGTTGCTAGAGTTGTTGT-3’;
gndA-F:5’-ATGTCTGGTCCTGTTGCTCGA-3’;
gndA-R:5’-TTAAGCCTGGTAGGTAGAGGCAG-3’;
The linearization carrier contains benomyl resistance geneBenA expression vector pDHt-SK-BenA,Benthe A gene sequence is shown as SEQ ID NO. 5.
2. The use of the recombinant strain of Cordyceps militaris constructed by the method of claim 1 for accumulating cordycepin in a submerged liquid fermentation system.
3. The use according to claim 2, wherein the recombinant strain of Cordyceps militaris is prepared by subjecting a recombinant strain of Cordyceps militaris to submerged fermentation in a synthetic medium comprising glucose, inorganic salts, amino acids and vitamin B to accumulate cordycepin 1 。
4. Use according to claim 3, characterized in that the synthetic medium comprises in particular: 20-50g/L glucose, 5-10g/L ammonium sulfate, 0.5-1g/L dipotassium phosphate, 0.5-1g/L potassium dihydrogen phosphate, 0.5-10g/L magnesium sulfate, 0.5-15g/L zinc sulfate, 5-10g/L glycine, 0.5-1g/L aspartic acid, 0.5-2g/L glutamine, 0.1-0.5g/L tyrosine, 0.05-0.2g/L cysteine, 0.5-1g/L leucine, 0.5-2g/L lysine, 0.05-0.5g/L phenylalanine, 0.1-1 g/L vitamin B 1 。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210150422.1A CN114717250B (en) | 2022-02-18 | 2022-02-18 | Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210150422.1A CN114717250B (en) | 2022-02-18 | 2022-02-18 | Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114717250A CN114717250A (en) | 2022-07-08 |
CN114717250B true CN114717250B (en) | 2024-02-02 |
Family
ID=82235679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210150422.1A Active CN114717250B (en) | 2022-02-18 | 2022-02-18 | Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114717250B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112239728A (en) * | 2020-10-30 | 2021-01-19 | 大连工业大学 | Synthetic culture medium containing reductive glutathione and suitable for cordyceps militaris culture, preparation method and application |
-
2022
- 2022-02-18 CN CN202210150422.1A patent/CN114717250B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112239728A (en) * | 2020-10-30 | 2021-01-19 | 大连工业大学 | Synthetic culture medium containing reductive glutathione and suitable for cordyceps militaris culture, preparation method and application |
Non-Patent Citations (5)
Title |
---|
CCM_06983 glucose-6-phosphate 1-dehydrogenase (G6PD) [Cordyceps militaris CM01];无;NCBI Reference Sequence: XP_006672184.1;1-2 * |
Cordyceps militaris CM01 6-phosphogluconate dehydrogenase (CCM_06873), partial mRNA;无;NCBI Reference Sequence: XM_006672011.1;1-2 * |
产虫草素酿酒酵母工程菌株的构建与发酵优化;霍春红 等;生物工程学报;第37卷(第9期);3334-3347 * |
植物生长调节剂促进蛹虫草液体表面培养生产虫草素;汤佳鹏;汪建雄;;食品工业科技(第10期);122-127 * |
蛹虫草菌生物合成虫草素的研究进展;赵星月;李倩;刘文静;关海晴;李成;王际辉;王亮;;生物工程学报(第07期);1293-1304 * |
Also Published As
Publication number | Publication date |
---|---|
CN114717250A (en) | 2022-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114107078B (en) | Genetic engineering bacterium for producing valencene, construction method and application thereof | |
CN110914435A (en) | Yeast producing ectoin | |
JP5496356B2 (en) | Xylitol producing strain introduced with arabinose metabolic pathway and xylitol producing method using the same | |
CN110804561B (en) | Saccharomyces cerevisiae with high yield of C6-C10 ethyl ester and construction method and application thereof | |
CN115786140A (en) | High-yield gibberellin GA 3 The gene engineering bacterium, the construction method and the application | |
CN113073074B (en) | Genetically engineered bacterium for efficiently synthesizing riboflavin and application thereof | |
CN112608936B (en) | Promoter for regulating and controlling expression of exogenous gene of yeast, regulating and controlling method and application thereof | |
CN114317587B (en) | Method for improving cordycepin yield by over-expressing glutathione peroxidase gene | |
JP7072809B2 (en) | Use in the production of recombinant microorganisms, their production methods and coenzyme Q10 | |
CN114717250B (en) | Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application | |
CN114806995B (en) | Construction and application of genetically engineered bacterium for efficiently synthesizing tetrahydropyrimidine based on acetyl-CoA metabolic modification | |
CN117511831A (en) | Construction method of ergothioneine-producing escherichia coli | |
CN115058374B (en) | Recombinant zymomonas mobilis for synthesizing acetoin by utilizing pyruvic acid as well as construction method and application thereof | |
CN107325976B (en) | Saccharomyces cerevisiae gene engineering bacterium capable of efficiently utilizing glucose and construction method and application thereof | |
CN109929853B (en) | Application of thermophilic bacteria source heat shock protein gene | |
CN115896211A (en) | Genetic engineering bacterium for producing citicoline by fermentation and application | |
CN108913732B (en) | Method for heterologous production of monacolin J and application | |
KR101175418B1 (en) | Novel xylitol dehydrogenase and method for producing xylitol using the same | |
WO2019233853A1 (en) | Microorganisms and the production of fine chemicals | |
CN114107355B (en) | Fermentation method of engineering bacteria for efficiently expressing glucose dehydrogenase and application of fermentation method | |
KR102613937B1 (en) | Yeast strain in which all genes involved in galactose utilization are deleted and method for producing recombinant protein using the same | |
CN114606146B (en) | Yeast for producing D-limonene and application thereof | |
CN116286899B (en) | NADH kinase gene RkNADHK1 and application thereof | |
CN106636251B (en) | Method for high yield of D-ribose by using bacillus subtilis engineering bacteria | |
CA2485489A1 (en) | Nucleotide sequence coding for a mannitol 2-dehydrogenase and method for the production of d-mannitol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |